BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33394027)

  • 21. Oligomerization is crucial for the stability and function of heme oxygenase-1 in the endoplasmic reticulum.
    Hwang HW; Lee JR; Chou KY; Suen CS; Hwang MJ; Chen C; Shieh RC; Chau LY
    J Biol Chem; 2009 Aug; 284(34):22672-9. PubMed ID: 19556236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heme oxygenase isoforms differ in their subcellular trafficking during hypoxia and are differentially modulated by cytochrome P450 reductase.
    Linnenbaum M; Busker M; Kraehling JR; Behrends S
    PLoS One; 2012; 7(4):e35483. PubMed ID: 22545110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human heme oxygenase-1 efficiently catabolizes heme in the absence of biliverdin reductase.
    Reed JR; Huber WJ; Backes WL
    Drug Metab Dispos; 2010 Nov; 38(11):2060-6. PubMed ID: 20679134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional and posttranslational mechanisms modulating the expression of the cytochrome P450 1A1 gene by lead in HepG2 cells: a role of heme oxygenase.
    Korashy HM; El-Kadi AO
    Toxicology; 2012 Jan; 291(1-3):113-21. PubMed ID: 22120038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by 2-phenyl-2-(1-piperidinyl)propane.
    Chun J; Kent UM; Moss RM; Sayre LM; Hollenberg PF
    Drug Metab Dispos; 2000 Aug; 28(8):905-11. PubMed ID: 10901699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mercury modulates the CYP1A1 at transcriptional and posttranslational levels in human hepatoma HepG2 cells.
    Amara IE; Anwar-Mohamed A; El-Kadi AO
    Toxicol Lett; 2010 Dec; 199(3):225-33. PubMed ID: 20837117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formation of P450 ยท P450 complexes and their effect on P450 function.
    Reed JR; Backes WL
    Pharmacol Ther; 2012 Mar; 133(3):299-310. PubMed ID: 22155419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The iron chaperone poly(rC)-binding protein 2 forms a metabolon with the heme oxygenase 1/cytochrome P450 reductase complex for heme catabolism and iron transfer.
    Yanatori I; Richardson DR; Toyokuni S; Kishi F
    J Biol Chem; 2017 Aug; 292(32):13205-13229. PubMed ID: 28655775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
    Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP
    Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytochrome P450 CYP1A1 accumulates in the cytosol of kidney and brain and is activated by heme.
    Meyer RP; Podvinec M; Meyer UA
    Mol Pharmacol; 2002 Nov; 62(5):1061-7. PubMed ID: 12391268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Organization of multiple cytochrome P450s with NADPH-cytochrome P450 reductase in membranes.
    Backes WL; Kelley RW
    Pharmacol Ther; 2003 May; 98(2):221-33. PubMed ID: 12725870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and characterization of full-length human heme oxygenase-1: the presence of intact membrane-binding region leads to increased binding affinity for NADPH cytochrome P450 reductase.
    Huber WJ; Backes WL
    Biochemistry; 2007 Oct; 46(43):12212-9. PubMed ID: 17915953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of cytochrome P450 1A2-mediated metabolism and production of reactive oxygen species by heme oxygenase-1 in rat liver microsomes.
    Reed JR; Cawley GF; Backes WL
    Drug Metab Lett; 2011 Jan; 5(1):6-16. PubMed ID: 20942796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The reactions of heme- and verdoheme-heme oxygenase-1 complexes with FMN-depleted NADPH-cytochrome P450 reductase. Electrons required for verdoheme oxidation can be transferred through a pathway not involving FMN.
    Higashimoto Y; Sato H; Sakamoto H; Takahashi K; Palmer G; Noguchi M
    J Biol Chem; 2006 Oct; 281(42):31659-67. PubMed ID: 16928691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heme oxygenase-1 and NADPH cytochrome P450 reductase expression in experimental allergic encephalomyelitis: an expanded view of the stress response.
    Emerson MR; LeVine SM
    J Neurochem; 2000 Dec; 75(6):2555-62. PubMed ID: 11080209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigations of the posttranslational mechanism of arsenite-mediated downregulation of human cytochrome P4501A1 levels: the role of heme oxygenase-1.
    Bessette EE; Fasco MJ; Pentecost BT; Reilly A; Kaminsky LS
    J Biochem Mol Toxicol; 2009; 23(3):222-32. PubMed ID: 19526463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytochrome P450 (P450) isoenzyme specific dealkylation of alkoxyresorufins in rat brain microsomes.
    Dhawan A; Parmar D; Dayal M; Seth PK
    Mol Cell Biochem; 1999 Oct; 200(1-2):169-76. PubMed ID: 10569197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence supporting the interaction of CYP2B4 and CYP1A2 in microsomal preparations.
    Cawley GF; Zhang S; Kelley RW; Backes WL
    Drug Metab Dispos; 2001 Dec; 29(12):1529-34. PubMed ID: 11717170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heteromeric complex formation between CYP2E1 and CYP1A2: evidence for the involvement of electrostatic interactions.
    Kelley RW; Cheng D; Backes WL
    Biochemistry; 2006 Dec; 45(51):15807-16. PubMed ID: 17176103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mercury modulates the cytochrome P450 1a1, 1a2 and 1b1 in C57BL/6J mice: in vivo and in vitro studies.
    Amara IE; Anwar-Mohamed A; Abdelhamid G; El-Kadi AO
    Toxicol Appl Pharmacol; 2013 Feb; 266(3):419-29. PubMed ID: 23231920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.